About Generex Biotechnology
Generex Biotechnology is a company based in Miramar (United States) founded in 1983.. The company has 5 employees as of July 31, 2019. Generex Biotechnology has completed 6 acquisitions, including Altucell, Antigen Express and Emmaus Medical. Generex Biotechnology operates in a competitive market with competitors including Sana Biotechnology, Semma Therapeutics, Adocia, Rezolute and Cellino, among others.
- Headquarter Miramar, United States
- Employees 5 as on 31 Jul, 2019
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Generex Biotechnology Corp
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
$2 M (USD), Post-IPO
Aug 04, 2020
-
Investors
-
Employee Count
5
as on Jul 31, 2019
-
Investments & Acquisitions
Altucell
& 5 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Unlock access to complete
Funding Insights of Generex Biotechnology
- Total Funding Total Funding
- Total Rounds 6
- Last Round Post-IPO — $2.0M
-
First Round
First Round
(25 Jan 2011)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug, 2020 | Amount | Post-IPO - Generex Biotechnology | Valuation |
investors |
|
| Dec, 2019 | Amount | Post-IPO - Generex Biotechnology | Valuation |
investors |
|
| Aug, 2012 | Amount | Post-IPO - Generex Biotechnology | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by Generex Biotechnology
Generex Biotechnology has strategically engaged in corporate development activities, having acquired 6 companies. Notable acquisitions include Altucell, Antigen Express and Emmaus Medical. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Regenerative therapies for neurodegenerative and autoimmune diseases are developed.
|
2010 | ||||
|
Regenerative medicines for gastrointestinal disorders are developed.
|
2009 | ||||
|
Emmaus Medical is engaged in developing treatments for rare diseases.
|
2000 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Generex Biotechnology
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Generex Biotechnology Comparisons
Competitors of Generex Biotechnology
Generex Biotechnology operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Sana Biotechnology, Semma Therapeutics, Adocia, Rezolute and Cellino, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Genetically engineered cell therapies are developed for multiple disorders.
|
|
| domain | founded_year | HQ Location |
Provider of bio-artificial pancreas for Type 1 Diabetes treatment
|
|
| domain | founded_year | HQ Location |
Therapeutics for diabetes and obesity treatment are developed.
|
|
| domain | founded_year | HQ Location |
Therapies for metabolic and orphan diseases are developed by Rezolute.
|
|
| domain | founded_year | HQ Location |
Developer of autologous cell therapies
|
|
| domain | founded_year | HQ Location |
Pendulum is focused on developing advanced probiotic solutions.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Generex Biotechnology
Frequently Asked Questions about Generex Biotechnology
When was Generex Biotechnology founded?
Generex Biotechnology was founded in 1983 and raised its 1st funding round 28 years after it was founded.
Where is Generex Biotechnology located?
Generex Biotechnology is headquartered in Miramar, United States. It is registered at Miramar, Florida, United States.
How many employees does Generex Biotechnology have?
As of Jul 31, 2019, the latest employee count at Generex Biotechnology is 5.
What does Generex Biotechnology do?
Generex Biotechnology was founded in 1983 in Miramar, United States, within the biotechnology sector. Focus is placed on proprietary drug delivery technologies, including the RapidMist device for buccal administration of drugs via the mouths inner lining. Operations center on products such as Generex Oral-lyn, a buccal insulin spray, targeting metabolic and immunological diseases through non-invasive methods.
Who are the top competitors of Generex Biotechnology?
Generex Biotechnology's top competitors include Sana Biotechnology, Semma Therapeutics and Adocia.
How many acquisitions has Generex Biotechnology made?
Generex Biotechnology has made 6 acquisitions, including Altucell, Antigen Express, and Emmaus Medical.